-
1
-
-
0031952586
-
Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men
-
Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 1998;26:1-12.
-
(1998)
Clin Infect Dis
, vol.26
, pp. 1-12
-
-
Craig, W.A.1
-
2
-
-
2142760947
-
Antimicrobial pharmacodynamics: Interactions of bug and drug
-
Drusano GL. Antimicrobial pharmacodynamics: interactions of 'bug and drug.' Natl Rev Microbiol 2004;2:289-300.
-
(2004)
Natl Rev Microbiol
, vol.2
, pp. 289-300
-
-
Drusano, G.L.1
-
3
-
-
0027161344
-
Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients
-
Forrest A, Nix DE, Ballow CH, Goss TF, Birmingham MC, Schentag JJ. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrob Agents Chemother 1993;37:1073-81.
-
(1993)
Antimicrob Agents Chemother
, vol.37
, pp. 1073-1081
-
-
Forrest, A.1
Nix, D.E.2
Ballow, C.H.3
Goss, T.F.4
Birmingham, M.C.5
Schentag, J.J.6
-
4
-
-
0032515386
-
Pharmacodynamics of levofloxacin: A new paradigm for early clinical trials
-
Preston SL, Drusano GL, Berman AL, et al. Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials. JAMA 1998;279:125-9.
-
(1998)
JAMA
, vol.279
, pp. 125-129
-
-
Preston, S.L.1
Drusano, G.L.2
Berman, A.L.3
-
5
-
-
2442549489
-
The relationship between fluoroquinolone area under the curve: Minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia
-
Drusano GL, Preston SL, Fowler C, Corrado M, Weisinger B, Kahn J. The relationship between fluoroquinolone area under the curve: minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia. J Infect Dis 2004;189:1590-7.
-
(2004)
J Infect Dis
, vol.189
, pp. 1590-1597
-
-
Drusano, G.L.1
Preston, S.L.2
Fowler, C.3
Corrado, M.4
Weisinger, B.5
Kahn, J.6
-
6
-
-
0034812780
-
Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections
-
Ambrose PG, Grasela DM, Grasela TH, Passarell J, Mayer HB, Pierce PF. Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections. Antimicrob Agents Chemother 2001;45:2793-7.
-
(2001)
Antimicrob Agents Chemother
, vol.45
, pp. 2793-2797
-
-
Ambrose, P.G.1
Grasela, D.M.2
Grasela, T.H.3
Passarell, J.4
Mayer, H.B.5
Pierce, P.F.6
-
7
-
-
19544366269
-
Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin
-
Bosnar M, Kelneric Z, Munic V, Erakovic V, Parnham MJ. Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin. Antimicrob Agents Chemother 2005;49:2372-7.
-
(2005)
Antimicrob Agents Chemother
, vol.49
, pp. 2372-2377
-
-
Bosnar, M.1
Kelneric, Z.2
Munic, V.3
Erakovic, V.4
Parnham, M.J.5
-
8
-
-
0026454434
-
In vitro demonstration of transport and delivery of antibiotics by polymorphonuclear leukocytes
-
Frank MO, Sullivan GW, Carper HT, Mandell GL. In vitro demonstration of transport and delivery of antibiotics by polymorphonuclear leukocytes. Antimicrob Agents Chemother 1992;36:2584-8.
-
(1992)
Antimicrob Agents Chemother
, vol.36
, pp. 2584-2588
-
-
Frank, M.O.1
Sullivan, G.W.2
Carper, H.T.3
Mandell, G.L.4
-
9
-
-
0035016761
-
Uptake, transport, and delivery of antimicrobial agents by human polymorphonuclear neutrophils
-
Mandell GL, Coleman E. Uptake, transport, and delivery of antimicrobial agents by human polymorphonuclear neutrophils. Antimicrob Agents Chemother 2001;45:1794-8.
-
(2001)
Antimicrob Agents Chemother
, vol.45
, pp. 1794-1798
-
-
Mandell, G.L.1
Coleman, E.2
-
10
-
-
0024522884
-
In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: Possible mechanism of delivery and release at sites of infection
-
Gladue RP, Bright GM, Isaacson RE, Newborg MF. In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob Agents Chemother 1989;33:277-82.
-
(1989)
Antimicrob Agents Chemother
, vol.33
, pp. 277-282
-
-
Gladue, R.P.1
Bright, G.M.2
Isaacson, R.E.3
Newborg, M.F.4
-
11
-
-
0027240065
-
Preferential concentration of azithromycin in an infected mouse thigh model
-
Retsema JA, Bergeron JM, Girard D, Milisen WB, Girard AE. Preferential concentration of azithromycin in an infected mouse thigh model. J Antimicrob Chemother 1993;31(suppl E):5-16.
-
(1993)
J Antimicrob Chemother
, vol.31
, Issue.SUPPL. E
, pp. 5-16
-
-
Retsema, J.A.1
Bergeron, J.M.2
Girard, D.3
Milisen, W.B.4
Girard, A.E.5
-
12
-
-
0026054990
-
Azithromycin concentrations in sinus fluid and mucosa after oral administration
-
Karma P, Pukander J, Penttila M. Azithromycin concentrations in sinus fluid and mucosa after oral administration. Eur J Clin Microbiol Infect Dis 1991;10:856-9.
-
(1991)
Eur J Clin Microbiol Infect Dis
, vol.10
, pp. 856-859
-
-
Karma, P.1
Pukander, J.2
Penttila, M.3
-
13
-
-
0041767551
-
Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults
-
Rodvold KA, Danziger LH, Gotfried MH. Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults. Antimicrob Agents Chemother 2003;47:2450-7.
-
(2003)
Antimicrob Agents Chemother
, vol.47
, pp. 2450-2457
-
-
Rodvold, K.A.1
Danziger, L.H.2
Gotfried, M.H.3
-
14
-
-
0030956116
-
Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers
-
Rodvold KA, Gotfried MH, Danziger LH, Servi RJ. Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers. Antimicrob Agents Chemother 1997;41:1399-402.
-
(1997)
Antimicrob Agents Chemother
, vol.41
, pp. 1399-1402
-
-
Rodvold, K.A.1
Gotfried, M.H.2
Danziger, L.H.3
Servi, R.J.4
-
15
-
-
0029797053
-
Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin
-
Patel KB, Xuan D, Tessier PR, Russomanno JH, Quintiliani R, Nightingale CH. Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin. Antimicrob Agents Chemother 1996;40:2375-9.
-
(1996)
Antimicrob Agents Chemother
, vol.40
, pp. 2375-2379
-
-
Patel, K.B.1
Xuan, D.2
Tessier, P.R.3
Russomanno, J.H.4
Quintiliani, R.5
Nightingale, C.H.6
-
16
-
-
0034986363
-
Lung concentrations of telithromycin after oral dosing
-
Khair OA, Andrews JM, Honeybourne D, Jevons G, Vacheron F, Wise R. Lung concentrations of telithromycin after oral dosing. J Antimicrob Chemother 2001;47:837-40.
-
(2001)
J Antimicrob Chemother
, vol.47
, pp. 837-840
-
-
Khair, O.A.1
Andrews, J.M.2
Honeybourne, D.3
Jevons, G.4
Vacheron, F.5
Wise, R.6
-
17
-
-
2942627414
-
Use of pharmacodynamic endpoints in the evaluation of gatifloxacin for the treatment of acute maxillary sinusitis
-
Ambrose PG, Anon JB, Owen JS, et al. Use of pharmacodynamic endpoints in the evaluation of gatifloxacin for the treatment of acute maxillary sinusitis. Clin Infect Dis 2004;38:1513-20.
-
(2004)
Clin Infect Dis
, vol.38
, pp. 1513-1520
-
-
Ambrose, P.G.1
Anon, J.B.2
Owen, J.S.3
-
18
-
-
0021889786
-
Performance of a diffusional clearance model for beta-lactam antimicrobial agents as influenced by extravascular protein binding and interstitial fluid kinetics
-
Fleishaker JC, McNamara PJ. Performance of a diffusional clearance model for beta-lactam antimicrobial agents as influenced by extravascular protein binding and interstitial fluid kinetics. Antimicrob Agents Chemother 1985;28:369-74.
-
(1985)
Antimicrob Agents Chemother
, vol.28
, pp. 369-374
-
-
Fleishaker, J.C.1
McNamara, P.J.2
-
20
-
-
0027395804
-
Single-dose intramuscular ceftriaxone for acute otitis media in children
-
Green SM, Rothrock SG. Single-dose intramuscular ceftriaxone for acute otitis media in children. Pediatrics 1993;91:23-30.
-
(1993)
Pediatrics
, vol.91
, pp. 23-30
-
-
Green, S.M.1
Rothrock, S.G.2
-
21
-
-
0031003965
-
Comparison of ceftriaxone and trimethoprim-sulfamethoxazole for acute otitis media. Greater Boston otitis media study group
-
Barnett ED, Teele DW, Klein JO, Cabral HJ, Kharasch SJ. Comparison of ceftriaxone and trimethoprim-sulfamethoxazole for acute otitis media. Greater Boston otitis media study group. Pediatrics 1997;99:23-8.
-
(1997)
Pediatrics
, vol.99
, pp. 23-28
-
-
Barnett, E.D.1
Teele, D.W.2
Klein, J.O.3
Cabral, H.J.4
Kharasch, S.J.5
-
22
-
-
0033023789
-
One dose ceftriaxone vs. ten days of amoxicillin/clavulanate therapy for acute otitis media: Clinical efficacy and change in nasopharyngeal flora
-
Cohen R, Navel M, Grunberg J, et al. One dose ceftriaxone vs. ten days of amoxicillin/clavulanate therapy for acute otitis media: clinical efficacy and change in nasopharyngeal flora. Pediatr Infect Dis J 1999;18:403-9.
-
(1999)
Pediatr Infect Dis J
, vol.18
, pp. 403-409
-
-
Cohen, R.1
Navel, M.2
Grunberg, J.3
-
23
-
-
1842732534
-
Intramuscular ceftriaxone in comparison with oral amoxicillin-clavulanate for the treatment of acute otitis media in infants and children
-
Wang CY, Lu CY, Hsieh YC, Lee CY, Huang LM. Intramuscular ceftriaxone in comparison with oral amoxicillin-clavulanate for the treatment of acute otitis media in infants and children. J Microbiol Immunol Infect 2004;37:57-62.
-
(2004)
J Microbiol Immunol Infect
, vol.37
, pp. 57-62
-
-
Wang, C.Y.1
Lu, C.Y.2
Hsieh, Y.C.3
Lee, C.Y.4
Huang, L.M.5
-
24
-
-
29044441713
-
Explaining the poor bacteriological eradication rate of single-dose ceftriaxone in Group a streptococcal tonsillopharyngitis: A reverse engineering solution using pharmacodynamic modeling
-
Blumer JL, Reed MD, Kaplan EL, Drusano GL. Explaining the poor bacteriological eradication rate of single-dose ceftriaxone in Group A streptococcal tonsillopharyngitis: a reverse engineering solution using pharmacodynamic modeling. Pediatrics 2005;116:927-32.
-
(2005)
Pediatrics
, vol.116
, pp. 927-932
-
-
Blumer, J.L.1
Reed, M.D.2
Kaplan, E.L.3
Drusano, G.L.4
-
25
-
-
0034878276
-
An adaptive grid, non-parametric approach to pharmacokinetic and dynamic (PK/PD) models
-
Bethesda, MD: IEEE Computer Society
-
Leary RJ, Schumitzky A, van Guilder M. An adaptive grid, non-parametric approach to pharmacokinetic and dynamic (PK/PD) models. In: Proceedings, 14th IEEE symposium on computer-based medical systems. Bethesda, MD: IEEE Computer Society, 2001:389-94.
-
(2001)
Proceedings, 14th IEEE Symposium on Computer-based Medical Systems
, pp. 389-394
-
-
Leary, R.J.1
Schumitzky, A.2
Van Guilder, M.3
-
26
-
-
0036720521
-
Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae
-
Lonks JR, Garau J, Gomez L, et al. Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae. Clin Infect Dis 2002;35:556-64.
-
(2002)
Clin Infect Dis
, vol.35
, pp. 556-564
-
-
Lonks, J.R.1
Garau, J.2
Gomez, L.3
-
27
-
-
3042577490
-
Differential efficacy of clarithromycin in lung vs thigh infection models
-
Maglio D, Capitano B, Banavicius MA, Geng Q, Nightingale CH, Nicolau DP. Differential efficacy of clarithromycin in lung vs thigh infection models. Chemotherapy 2004;50:63-6.
-
(2004)
Chemotherapy
, vol.50
, pp. 63-66
-
-
Maglio, D.1
Capitano, B.2
Banavicius, M.A.3
Geng, Q.4
Nightingale, C.H.5
Nicolau, D.P.6
-
28
-
-
0036975207
-
In vivo pharmacodynamic evaluation of clarithromycin in comparison to erythromycin
-
Novelli A, Fallani S, Cassetta MI, Arrigucci S, Mazzel T. In vivo pharmacodynamic evaluation of clarithromycin in comparison to erythromycin. J Chemother 2002;14:584-90.
-
(2002)
J Chemother
, vol.14
, pp. 584-590
-
-
Novelli, A.1
Fallani, S.2
Cassetta, M.I.3
Arrigucci, S.4
Mazzel, T.5
-
29
-
-
0036235528
-
Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia
-
Tessier PR, Kim MK, Zhou W, et al. Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia. Antimicrob Agents Chemother 2002;46:1425-34.
-
(2002)
Antimicrob Agents Chemother
, vol.46
, pp. 1425-1434
-
-
Tessier, P.R.1
Kim, M.K.2
Zhou, W.3
-
30
-
-
11244342348
-
Pharmacodynamic profile of telithromycin against macrolide- and fluoroquinolone-resistant Streptococcus pneumoniae in a neutropenic mouse thigh model
-
Tessier PR, Mattoes HM, Dandekar PK, Nightingale CH, Nicolau DP. Pharmacodynamic profile of telithromycin against macrolide- and fluoroquinolone-resistant Streptococcus pneumoniae in a neutropenic mouse thigh model. Antimicrob Agents Chemother 2005;49:188-94.
-
(2005)
Antimicrob Agents Chemother
, vol.49
, pp. 188-194
-
-
Tessier, P.R.1
Mattoes, H.M.2
Dandekar, P.K.3
Nightingale, C.H.4
Nicolau, D.P.5
-
31
-
-
19544384399
-
Assessment of the efficacy of telithromycin simulating human exposures against S. pneumoniae with ribosomal mutations in a murine pneumonia model
-
Dandekar PK, Williams P, Tessier PR, Farrell DJ, Nightingale CH, Nicolau DP. Assessment of the efficacy of telithromycin simulating human exposures against S. pneumoniae with ribosomal mutations in a murine pneumonia model. Int J Antimicrob Agents 2005;25:530-4.
-
(2005)
Int J Antimicrob Agents
, vol.25
, pp. 530-534
-
-
Dandekar, P.K.1
Williams, P.2
Tessier, P.R.3
Farrell, D.J.4
Nightingale, C.H.5
Nicolau, D.P.6
-
32
-
-
18244382544
-
Pharmacodynamic activity of telithromycin at simulated clinically achievable free-drug concentrations in serum and epithelial lining fluid against efflux (mefE)-producing macrolide-resistant Streptococcus pneumoniae for which telithromycin MICs vary
-
Zhanel GG, Johanson C, Laing N, Hisananga T, Wierzbowski A, Hoban DJ. Pharmacodynamic activity of telithromycin at simulated clinically achievable free-drug concentrations in serum and epithelial lining fluid against efflux (mefE)-producing macrolide-resistant Streptococcus pneumoniae for which telithromycin MICs vary. Antimicrob Agents Chemother 2005;49:1943-8.
-
(2005)
Antimicrob Agents Chemother
, vol.49
, pp. 1943-1948
-
-
Zhanel, G.G.1
Johanson, C.2
Laing, N.3
Hisananga, T.4
Wierzbowski, A.5
Hoban, D.J.6
|